[ad_1]
Brazil, the country with the second-highest coronavirus death toll, passed the 10-million mark for reported infections Thursday, amid a deadly second wave and problems with its vaccination campaign.
The country became the third to reach the grim mark—after the United States and India—with more than 51,900 new infections in 24 hours, according to official data.
Over the same one-day period, 1,367 people died, bringing the total to over 243,400.
Brazil’s figure of 10,030,626 came amid mounting criticism of how President Jair Bolsonaro’s government has handled the epidemic and a vaccination response.
So far, three percent of the population of 212 million have received one of two required vaccine doses.
The month-old campaign with China’s CoronaVac and the AstraZeneca shot, has had to be stopped in several cities and towns, however, due to a shortage of doses—including in Rio de Janeiro.
Health Minister Eduardo Pazuello said this week that the country would have 230 million doses by the end of July. But this depends on the delivery of doses from abroad, as well as shipment of component parts for fabrication in Brazil.
The government’s plan also depends on 10 million doses of the Russian Sputnik V vaccine and 20 million of India’s Covaxin. Brazil has not yet finalized contracts with these two countries.
As Brazil battles a second infection wave, it also has to deal with a new virus variant, thought to be more contagious, rapidly spreading around the country.
Follow the latest news on the coronavirus (COVID-19) outbreak
© 2021 AFP
Citation:
Brazil passes 10 mn coronavirus infections (2021, February 19)
retrieved 19 February 2021
from https://medicalxpress.com/news/2021-02-brazil-mn-coronavirus-infections.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
[ad_2]
Source link
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022
